ApprovalTrail

Drug · DIN 02435527

JAMP-AMITRIPTYLINE TABLETS

Authorized, but not sold for a year or more

Authorized, but the company reports it has not been sold in Canada for at least 12 months.

Status Dormant since July 31, 2023; first marketed January 12, 2015.
Drug Identification Number (DIN)
02435527
Company (DIN owner)
JAMP Pharma CorporationBoucherville, Quebec, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Amitriptyline N06AA09
Class
Human
Record last updated
June 23, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
AMITRIPTYLINE HYDROCHLORIDE10 MG

Other DINs named JAMP-AMITRIPTYLINE TABLETS